Case Report

Korean J Hematol 2006; 41(3):

Published online September 30, 2006

https://doi.org/10.5045/kjh.2006.41.3.208

© The Korean Society of Hematology

성인 급성골수성백혈병에서 저강도 동종 제대혈이식 4예

정소영, 장문주, 강명서, 백진영, 장세경, 최영길, 오도연

포천중문의과대학교, 내과학교실, 진단검사의학교실, 차병원, 제대혈은행 아이코드, 방사선종양학과

Reduced-intensity Umbilical Cord Blood Transplantation in Adult Acute Myeloid Leukemia: Report of Four Cases

So Young Chong, Moon Ju Jang, Myung Seo Kang, Jin Young Baek, Sei Kyung Chang, Young Kil Choi, Do yeon Oh

Departments of, Internal Medicine, Laboratory Medicine, icord Cord Blood Bank, Radiation Oncology,
Pochon CHA University College of Medicine, Seongnam, Korea

Abstract

The outcome after unrelated cord blood transplantation (CBT) is similar to that of matched unrelated bone marrow transplantation in children, and the results of CBT in adult patients has recently shown improvement. In addition, the use of reduced-intensity conditioning regimens for CBT has shown stable engraftment and reduced treatment-related mortality (TRM). From May 2005 to Jan 2006, four adult patients with acute myelogenous leukemia were treated with CBT after reduced-intensity conditioning at our hospital. The mean age of patients was 53.8 yrs, and all patients received 2 HLA antigen mismatched single unit cord blood. The infused mean cell dose was 2.85×107/kg for total nucleated cells and 0.72×105/kg for CD34+ cells. All patients had engraftment. The mean number of days to WBC and platelet engraftment was D+20.3 and D+60.3, respectively. There was no TRM within 100 days after transplantation. At the last follow up, three of the four patients were alive. One patient transplanted in first complete remisson is alive in remission at day 413, but the other patients transplanted in advanced disease all relapsed. Reduced-intensity CBT is a feasible approach in selected adult patients with acute myeloid leukemia.

Keywords Cord blood transplantation, Reduced-intensity conditioning, Acute myelogenous leukemia

Article

Case Report

Korean J Hematol 2006; 41(3): 208-214

Published online September 30, 2006 https://doi.org/10.5045/kjh.2006.41.3.208

Copyright © The Korean Society of Hematology.

성인 급성골수성백혈병에서 저강도 동종 제대혈이식 4예

정소영, 장문주, 강명서, 백진영, 장세경, 최영길, 오도연

포천중문의과대학교, 내과학교실, 진단검사의학교실, 차병원, 제대혈은행 아이코드, 방사선종양학과

Reduced-intensity Umbilical Cord Blood Transplantation in Adult Acute Myeloid Leukemia: Report of Four Cases

So Young Chong, Moon Ju Jang, Myung Seo Kang, Jin Young Baek, Sei Kyung Chang, Young Kil Choi, Do yeon Oh

Departments of, Internal Medicine, Laboratory Medicine, icord Cord Blood Bank, Radiation Oncology,
Pochon CHA University College of Medicine, Seongnam, Korea

Abstract

The outcome after unrelated cord blood transplantation (CBT) is similar to that of matched unrelated bone marrow transplantation in children, and the results of CBT in adult patients has recently shown improvement. In addition, the use of reduced-intensity conditioning regimens for CBT has shown stable engraftment and reduced treatment-related mortality (TRM). From May 2005 to Jan 2006, four adult patients with acute myelogenous leukemia were treated with CBT after reduced-intensity conditioning at our hospital. The mean age of patients was 53.8 yrs, and all patients received 2 HLA antigen mismatched single unit cord blood. The infused mean cell dose was 2.85×107/kg for total nucleated cells and 0.72×105/kg for CD34+ cells. All patients had engraftment. The mean number of days to WBC and platelet engraftment was D+20.3 and D+60.3, respectively. There was no TRM within 100 days after transplantation. At the last follow up, three of the four patients were alive. One patient transplanted in first complete remisson is alive in remission at day 413, but the other patients transplanted in advanced disease all relapsed. Reduced-intensity CBT is a feasible approach in selected adult patients with acute myeloid leukemia.

Keywords: Cord blood transplantation, Reduced-intensity conditioning, Acute myelogenous leukemia

Blood Res
Volume 59 2024

Stats or Metrics

Share this article on

  • line

Related articles in BR

Blood Research

pISSN 2287-979X
eISSN 2288-0011
qr-code Download